Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02649582
Brief Title: Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients (ADDIT-GLIO)

First Submitted : January 23, 2015
First Submitted that Met QC Criteria : January 5, 2016
First Posted : January 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 15, 2021
Last Update Posted : January 19, 2021